Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery
暂无分享,去创建一个
Ryan F. Donnelly | Desmond I. J. Morrow | Paul A. McCarron | P. McCarron | R. Donnelly | A. Woolfson | A. D. Woolfson | D. I. Morrow
[1] T. Tsai,et al. Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study. , 2007, Biological & pharmaceutical bulletin.
[2] Kanji Takada,et al. Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] M. Heit,et al. Transdermal lontophoretic Delivery of Luteinizing Hormone Releasing Hormone (LHRH): Effect of Repeated Administration , 1994, Pharmaceutical Research.
[4] Chung-Hong Hu,et al. Transdermal delivery of macromolecules by erbium:YAG laser. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[5] Akira Kato,et al. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride , 1987, The Journal of pharmacy and pharmacology.
[6] Wijaya Martanto,et al. Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.
[7] P. Paronen,et al. Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. , 1996, Biochimica et biophysica acta.
[8] M. Hussain,et al. Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines , 1990, Pharmaceutical Research.
[9] M. Ashburn,et al. A Pilot Study Assessing the Impact of Heat on the Transdermal Delivery of Testosterone , 2001, Journal of clinical pharmacology.
[10] F. Tse,et al. Effect of Current Magnitude and Drug Concentration on lontophoretic Delivery of Octreotide Acetate (Sandostatin®) in the Rabbit , 1994, Pharmaceutical Research.
[11] Adrian C. Williams,et al. Can drug‐bearing liposomes penetrate intact skin? , 2006, The Journal of pharmacy and pharmacology.
[12] Sion A. Coulman,et al. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. , 2006, Current drug delivery.
[13] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[14] E. Peira,et al. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. , 2002, International journal of pharmaceutics.
[15] H. Benson. Transfersomes for transdermal drug delivery , 2006, Expert opinion on drug delivery.
[16] R. Guy,et al. Transdermal drug delivery : developmental issues and research initiatives , 1989 .
[17] W. J. Irwin,et al. Phonophoresisis it a reality , 1995 .
[18] J. Hadgraft. Skin, the final frontier. , 2001, International journal of pharmaceutics.
[19] Y. Kalia,et al. Transdermal Iontophoretic Delivery of Vapreotide Acetate AcrossPorcine Skin in Vitro , 2005, Pharmaceutical Research.
[20] W. Wohlrab,et al. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. , 1989, Dermatologische Monatschrift.
[21] E. Peira,et al. Deformable liposomes for dermal administration of methotrexate. , 2004, International journal of pharmaceutics.
[22] B. W. Barry,et al. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. , 1988, The Journal of investigative dermatology.
[23] Adrian C. Williams,et al. Penetration enhancers. , 2004, Advanced drug delivery reviews.
[24] Gary P. Martin,et al. Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.
[25] S. Majumdar,et al. Topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of theophylline (ThH). , 2007, International journal of pharmaceutics.
[26] S. Singh,et al. Transdermal drug delivery by passive diffusion and iontophoresis: A review , 1993, Medicinal research reviews.
[27] Y. Chien,et al. Controlled drug release from polymeric delivery devices V: Hydroxy group effects on drug release kinetics and thermodynamics. , 1979, Journal of pharmaceutical sciences.
[28] J. W. Wiechers,et al. The barrier function of the skin in relation to percutaneous absorption of drugs , 1989, Pharmaceutisch Weekblad.
[29] Jagdish Singh,et al. Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: Permeability and fourier transform infrared spectroscopy studies , 2008, AAPS PharmSciTech.
[30] Priya Batheja,et al. Transdermal iontophoresis. , 2006, Expert opinion on drug delivery.
[31] J. Tsai,et al. Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin , 2003, Archives of Dermatological Research.
[32] R. Stoughton. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. , 1982, Archives of dermatology.
[33] T. Senderovitz,et al. Pharmacokinetics and Pharmacodynamics of a New Formulation of Recombinant Human Growth Hormone Administered by ZomaJet 2 Vision, a New Needle‐Free Device, Compared to Subcutaneous Administration Using a Conventional Syringe , 2002, Journal of clinical pharmacology.
[34] Mark R Prausnitz,et al. Precise microinjection into skin using hollow microneedles. , 2006, The Journal of investigative dermatology.
[35] Mark R Prausnitz,et al. Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.
[36] E. Shefter,et al. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides , 1986 .
[37] O. Abdallah,et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.
[38] I. Sugimoto,et al. Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. , 1987, Journal of pharmacobio-dynamics.
[39] A. Brodin,et al. Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase. , 1986, Journal of pharmaceutical sciences.
[40] A. Michaels,et al. Drug permeation through human skin: Theory and invitro experimental measurement , 1975 .
[41] N. A. Megrab,et al. Oestradiol permeation through human skin and silastic membrane : effects of propylene glycol and supersaturation , 1995 .
[42] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[43] N. Weiner,et al. The influence of particle size of liposomes on the deposition of drug into skin , 1994 .
[44] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Johan Moan,et al. Topical Application of 5-Aminolevulinic Acid Hexyl Ester and 5-Aminolevulinic Acid to Normal Nude Mouse Skin: Differences in Protoporphyrin IX Fluorescence Kinetics and the Role of the Stratum Corneum¶ , 2000, Photochemistry and photobiology.
[46] R. Heine,et al. The Medi‐Jector II: Efficacy and Acceptability in Insulin‐dependent Diabetic Patients With and Without Needle Phobia , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[47] Andreas G. Schätzlein,et al. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.
[48] Geoffrey Lee,et al. Drug permeation through human skin II: Permeability of ionizable compounds. , 1984, Journal of pharmaceutical sciences.
[49] R. Gurny,et al. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. , 2006, Molecular vision.
[50] S. Jain,et al. Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation , 2003, Drug development and industrial pharmacy.
[51] M. Foldvari,et al. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.
[52] Jagdish Singh,et al. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). , 2003, International journal of pharmaceutics.
[53] Taravat Ghafourian,et al. The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[54] G. Somers,et al. PERCUTANEOUS ABSORPTION , 1956, The Journal of pharmacy and pharmacology.
[55] Nicholas A Peppas,et al. Microfabricated drug delivery devices. , 2005, International journal of pharmaceutics.
[56] Howell G. M. Edwards,et al. Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum , 1995 .
[57] Xun Sun,et al. Enhanced liver targeting by synthesis ofN1-stearyl-5-Fu and incorporation into solid lipid nanoparticles , 2003, Archives of pharmacal research.
[58] R. Scheuplein,et al. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. , 1967, The Journal of investigative dermatology.
[59] S. Mitragotri,et al. Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.
[60] M. Ashburn,et al. Noninvasive drug delivery , 2001, Comprehensive therapy.
[61] E. Touitou,et al. Drug delivery across the skin , 2002, Expert opinion on biological therapy.
[62] K. Sugibayashi,et al. Effect of the absorption enhancer, Azone, on the transport of 5‐fluorouracil across hairless rat skin , 1985, The Journal of pharmacy and pharmacology.
[63] W. Wohlrab,et al. Penetration kinetics of liposomal hydrocortisone in human skin. , 1987, Dermatologica.
[64] M. Fehr,et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. , 2001, Gynecologic oncology.
[65] M. Roberts,et al. Ion‐pair Formation as a Strategy to Enhance Topical Delivery of Salicylic Acid , 2000, The Journal of pharmacy and pharmacology.
[66] Rainer H Müller,et al. Cosmetic applications for solid lipid nanoparticles (SLN). , 2003, International journal of pharmaceutics.
[67] B. W. Barry,et al. Skin absorption enhancers. , 1992, Critical reviews in therapeutic drug carrier systems.
[68] J. Yoshimitsu,et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.
[69] Q. Ping,et al. Enhanced transdermal delivery of tetracaine by electroporation. , 2000, International journal of pharmaceutics.
[70] Samir Mitragotri,et al. Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets , 2007, Proceedings of the National Academy of Sciences.
[71] I. H. Blank,et al. Further observations on factors which influence the water content of the stratum corneum. , 1953, The Journal of investigative dermatology.
[72] Hongzhuo Liu,et al. Effect of vehicles and enhancers on the topical delivery of cyclosporin A. , 2006, International journal of pharmaceutics.
[73] D. Notterman,et al. Alternative routes of drug administration - Advantages and disadvantages (subject review) , 1997 .
[74] B. Forbes,et al. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. , 2005, International journal of pharmaceutics.
[75] S L Jacques,et al. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. , 1991, The Journal of investigative dermatology.
[76] R. Panchagnula,et al. Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. , 2003, Pharmacological research.
[77] A. El‐Kattan,et al. Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.
[78] L. Maxwell,et al. Preanesthetic Medication of Children with Midazolam Using the Biojector Jet Injector , 1995, Anesthesiology.
[79] Christopher P. Thomas,et al. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull' effect. , 2006, International journal of pharmaceutics.
[80] Takaya Miyano,et al. Sugar Micro Needles as Transdermic Drug Delivery System , 2005, Biomedical microdevices.
[81] Eric W. Smith,et al. The Mystical Effects of Dermatological Vehicles , 2005, Dermatology.
[82] R. Panchagnula,et al. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[83] Y. Kalia,et al. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[84] B. Tashtoush,et al. Azathioprine transport through rat skin and its immunosuppressive effect. , 2004, Die Pharmazie.
[85] B. W. Barry,et al. Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. , 2001, International journal of pharmaceutics.
[86] H. Frasure,et al. Subcutaneous lidocaine delivered by jet-injector for pain control before IV catheterization in the ED: the patients' perception and preference. , 2002, The American journal of emergency medicine.
[87] Dinesh Mishra,et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. , 2006, Vaccine.
[88] S. Shen,et al. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. , 2002, Journal of pharmaceutical sciences.
[89] Nadine Barrie Smith,et al. Ultrasound Mediated Transdermal Insulin Delivery in Pigs Using a Lightweight Transducer , 2007, Pharmaceutical Research.
[90] Edmond Sabo,et al. Fear of injections in young adults: prevalence and associations. , 2003, The American journal of tropical medicine and hygiene.
[91] K. Sugibayashi,et al. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[92] Jhi-Joung Wang,et al. Transdermal delivery of nalbuphine and its prodrugs by electroporation. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[93] M. Nakano,et al. Evaluation of percutaneous absorption of midazolam by terpenes. , 2003, Drug metabolism and pharmacokinetics.
[94] H. Trommer,et al. Overcoming the Stratum Corneum: The Modulation of Skin Penetration , 2006, Skin Pharmacology and Physiology.
[95] Aarti Naik,et al. Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.
[96] T. Imai,et al. Evaluation of Stereoselective Transdermal Transport and Concurrent Cutaneous Hydrolysis of Several Ester Prodrugs of Propranolol: Mechanism of Stereoselective Permeation , 1996, Pharmaceutical Research.
[97] R. Scheuplein,et al. Percutaneous absorption of steroids. , 1969, The Journal of investigative dermatology.
[98] O. Abdallah,et al. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.
[99] N. A. Megrab,et al. Oestradiol permeation across human skin, silastic and snake skin membranes: The effects of ethanol/water co-solvent systems☆ , 1995 .
[100] R. Brodell,et al. The treatment of palmar and plantar warts using natural alpha interferon and a needleless injector. , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[101] Joseph Kost,et al. Ultrasound and transdermal drug delivery. , 2004, Drug discovery today.
[102] W H Smart,et al. The use of silicon microfabrication technology in painless blood glucose monitoring. , 2000, Diabetes technology & therapeutics.
[103] K. Svendsen,et al. Irritant cutaneous reactions to N‐methyl‐2‐pyrrolidone (NMP) , 1992, Contact dermatitis.
[104] Jung-Hwan Park,et al. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[105] J. Karras,et al. Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin. , 2005, The Journal of investigative dermatology.
[106] Vincent J. Sullivan,et al. Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.
[107] A. Singer,et al. Low-frequency sonophoresis: pathologic and thermal effects in dogs. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[108] S. Shen,et al. Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[109] Brian W. Barry,et al. Mode of action of penetration enhancers in human skin , 1987 .
[110] A. Rawlings,et al. Moisturization and skin barrier function , 2004, Dermatologic therapy.
[111] Mark R. Prausnitz,et al. Coating Formulations for Microneedles , 2007, Pharmaceutical Research.
[112] R. Malone,et al. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[113] M. Fujii,et al. Enhancement Effect of p‐Menthane‐3,8‐diol on In Vitro Permeation of Antipyrine and Indomethacin Through Yucatan Micropig Skin , 2004, Drug development and industrial pharmacy.
[114] S. Shen,et al. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. , 2006, Journal of pharmaceutical sciences.
[115] G. Stagni,et al. Effects of penetration enhancers on in vitro permeability of meloxicam gels. , 2007, International journal of pharmaceutics.
[116] K. Knutson,et al. Mechanism of Ethanol-Enhanced Estradiol Permeation Across Human Skin in Vivo , 1990, Pharmaceutical Research.
[117] L. Kang,et al. Reversible effects of permeation enhancers on human skin. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[118] S. Mitragotri,et al. Ultrasound-mediated transdermal protein delivery , 1995, Science.
[119] A. B. Prasad,et al. British National Formulary , 1994 .
[120] M. Cormier,et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.
[121] T. R. Krishnan,et al. Transdermal delivery of cyclosporin-A using electroporation. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[122] Y. Matsumoto,et al. Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1–34) , 2001, The Journal of pharmacy and pharmacology.
[123] Adrian C. Williams,et al. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.
[124] H. Benson,et al. Ion‐pairs of ibuprofen: increased membrane diffusion , 2004, The Journal of pharmacy and pharmacology.
[125] A. Wolf,et al. Rapid skin anaesthesia using high velocity lignocaine particles: a prospective placebo controlled trial , 2002, Archives of disease in childhood.
[126] T. Desai,et al. Microfabricated drug delivery systems: from particles to pores. , 2003, Advanced drug delivery reviews.
[127] G. E. El Maghraby,et al. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.
[128] J. Hadgraft,et al. Percutaneous delivery of carbamazepine and selected N-alkyl and N-hydroxyalkyl analogues. , 2004, International journal of pharmaceutics.
[129] Nili Grossman,et al. The nature of ultrasound-SLS synergism during enhanced transdermal transport. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[130] Chandra Sekhar Kolli,et al. Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery , 2007, Pharmaceutical Research.
[131] E. Young,et al. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. , 1968, Journal of pharmaceutical sciences.
[132] J. Eppstein,et al. Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats , 2007, Pharmaceutical Research.
[133] A. Tiwary,et al. Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. , 2006, Current drug delivery.
[134] J. Hadgraft,et al. The selection and design of topical and transdermal agents: a review. , 1998, The journal of investigative dermatology. Symposium proceedings.
[135] A. Tedesco,et al. Oleic Acid as Optimizer of the Skin Delivery of 5-Aminolevulinic Acid in Photodynamic Therapy , 2005, Pharmaceutical Research.
[136] W. Nimmo. The promise of transdermal drug delivery. , 1990, British journal of anaesthesia.
[137] R. Prankerd,et al. Transdermal delivery of 5-fluorouracil (5-FU) through hairless mouse skin by 1-alkyloxycarbonyl-5-FU prodrugs: Physicochemical characterization of prodrugs and correlations with transdermal delivery , 1994 .
[138] J. Hadgraft,et al. Penetration enhancement of ibuprofen from supersaturated solutions through human skin. , 2001, International journal of pharmaceutics.
[139] M. G. Rimoli,et al. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[140] R. Potts,et al. Lipid biophysics of water loss through the skin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[141] A. Blume,et al. Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids , 1993 .
[142] V. Rodilla,et al. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[143] M. Fujii,et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[144] Oliver A. Shergold,et al. The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. , 2006, Journal of biomechanics.
[145] S. Wissing,et al. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. , 2002, International journal of pharmaceutics.
[146] P. Dallas,et al. Ion Pair Formation as a Possible Mechanism for the Enhancement Effect of Lauric Acid on the Transdermal Permeation of Ondansetron , 2005, Pharmaceutical development and technology.
[147] N. Dixit,et al. Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.
[148] Gopinathan K Menon,et al. New insights into skin structure: scratching the surface. , 2002, Advanced drug delivery reviews.
[149] A. Nokhodchi,et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. , 2003, International journal of pharmaceutics.
[150] Mark G. Allen,et al. Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.
[151] T. Nevalainen,et al. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[152] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[153] Shishu,et al. Preparation of hydrogels of griseofulvin for dermal application. , 2006, International journal of pharmaceutics.
[154] J. Bouwstra,et al. Structural investigations of human stratum corneum by small-angle X-ray scattering. , 1991, The Journal of investigative dermatology.
[155] Mandip Singh,et al. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. , 2002, International journal of pharmaceutics.
[156] J. M. Marchetti,et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[157] N. Weiner,et al. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. , 1992, The Journal of investigative dermatology.
[158] M. Schäfer-Korting,et al. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. , 2000, International journal of pharmaceutics.
[159] L. Strekowski,,et al. Investigation of Iminosulfuranes as Novel Transdermal Penetration Enhancers: Enhancement Activity and Cytotoxicity , 2005, Pharmaceutical Research.
[160] C. Legault,et al. Development of New Jet Injector for Insulin Therapy , 1986, Diabetes Care.
[161] C. Chiang,et al. Control of drug crystallization in transdermal matrix system , 1996 .
[162] Dexiang Chen,et al. Epidermal powder immunization against influenza. , 2004, Vaccine.
[163] Regina Luttge,et al. Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .
[164] Huibi Xu,et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. , 2007, International journal of pharmaceutics.
[165] A. Fadda,et al. Niosomes as carriers for tretinoin. I. Preparation and properties. , 2002, International journal of pharmaceutics.
[166] B. W. Barry,et al. Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[167] R. Guy,et al. Iontophoretic Delivery of 5-Aminolevulinic Acid (ALA): Effect of pH , 2001, Pharmaceutical Research.
[168] C. Valenta,et al. Effects of Penetration Enhancers on the In‐vitro Percutaneous Absorption of Progesterone , 1997, The Journal of pharmacy and pharmacology.
[169] N. K. Jain,et al. Ethinylestradiol‐loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics , 2006, The Journal of pharmacy and pharmacology.
[170] L. Strekowski,,et al. Mechanistic studies on percutaneous penetration enhancement by N-(4-halobenzoyl)-S,S-dimethyliminosulfuranes Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500123-JLR200 , 2005, Journal of Lipid Research.
[171] G. Flynn,et al. Permeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skin , 1996, Pharmaceutical Research.
[172] J. A. Gimm,et al. Transdermal Delivery of Heparin by Skin Electroporation , 1995, Bio/Technology.
[173] M. Hussain,et al. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles. , 1990, Journal of pharmaceutical sciences.
[174] T. Higuchi,et al. Physical Chemical analysis of Percutaneous Absorption Process from Creams and Ointments , 1960 .
[175] M. Y. Kim,et al. Skin permeation of retinol in Tween 20‐based deformable liposomes: in‐vitro evaluation in human skin and keratinocyte models , 2006, The Journal of pharmacy and pharmacology.
[176] D. Monti,et al. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. , 2002, International journal of pharmaceutics.
[177] Gary P Moss,et al. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption , 2006, The Journal of pharmacy and pharmacology.
[178] S. Kitagawa,et al. Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion. , 2007, Chemical & pharmaceutical bulletin.
[179] D. Fuller,et al. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. , 2005, Vaccine.
[180] B. Müller,et al. Influence of Supersaturation on the Pharmacodynamic Effect of Bupranolol After Dermal Administration Using Microemulsions as Vehicle , 1992, Pharmaceutical Research.
[181] R. Baker,et al. Transdermal delivery of levonorgestrel I: Alkanols as permeation enhancers in vitro , 1988 .
[182] R. Müller,et al. Drug delivery to the brain--realization by novel drug carriers. , 2004, Journal of nanoscience and nanotechnology.
[183] G. Cevc,et al. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.
[184] N. Sadick,et al. Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating the Lidocaine/Tetracaine Patch for Induction of Local Anesthesia prior to Minor Dermatologic Procedures in Geriatric Patients , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[185] Melissa Ai Ling Teo,et al. In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.
[186] B. Godin,et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[187] E. Touitou,et al. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.
[188] O. Abdallah,et al. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. , 2007, Die Pharmazie.
[189] D. Zurakowski,et al. A Randomized Controlled Trial to Evaluate S-Caine Patch™ for Reducing Pain Associated with Vascular Access in Children , 2005, Anesthesiology.
[190] Haidar,et al. Transdermal testing: practical aspects and methods. , 2000, Pharmaceutical science & technology today.
[191] E. Eliav,et al. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[192] Wijaya Martanto,et al. Microinfusion Using Hollow Microneedles , 2006, Pharmaceutical Research.
[193] G. Cevc,et al. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.
[194] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[195] J. Hadgraft,et al. The dermal delivery of lignocaine: influence of ion pairing. , 2000, International journal of pharmaceutics.
[196] Y. Kalia,et al. Passive skin penetration enhancement and its quantification in vitro. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[197] Adrian C. Williams,et al. Transdermal and Topical Drug Delivery : From Theory to Clinical Practice , 2003 .
[198] M. Danhof,et al. Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[199] M. Ashburn,et al. Evaluating skin anesthesia after administration of a local anesthetic system consisting of an S-Caine patch and a controlled heat-aided drug delivery (CHADD) patch in volunteers. , 2000, The Clinical journal of pain.
[200] E. Zsigmond,et al. Painless intravenous catheterization by intradermal jet injection of lidocaine: a randomized trial. , 1999, Journal of clinical anesthesia.
[201] B. W. Barry,et al. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. , 1983, The Journal of investigative dermatology.
[202] E. Touitou,et al. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. , 1997, Journal of pharmaceutical sciences.
[203] B. Godin,et al. Enhanced delivery of drugs into and across the skin by ethosomal carriers , 2000 .
[204] B. Michniak,et al. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. , 1999, Drug development and industrial pharmacy.
[205] Meindert Danhof,et al. Transdermal Iontophoresis of Rotigotine Across Human Stratum Corneum in Vitro: Influence of pH and NaCl Concentration , 2004, Pharmaceutical Research.
[206] Yi Yan Yang,et al. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent. , 2005, International journal of pharmaceutics.
[207] P. Friedman,et al. Thirty‐Minute Application of the S‐Caine Peel Prior to Nonablative Laser Treatment , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[208] S. Santoyo,et al. Transdermal Iontophoresis and Skin Retention of Piroxicam from Gels Containing Piroxicam : Hydroxypropyl-β-cyclodextrin Complexes , 2001 .
[209] K. Higaki,et al. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. , 2005, International journal of pharmaceutics.
[210] E. Fabrizio,et al. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol , 2006 .
[211] Stanley B. Brown,et al. Comparative in vitro percutaneous penetration of 5‐aminolevulinic acid and two of its esters through excised hairless mouse skin , 2003, Lasers in surgery and medicine.
[212] M. Rother,et al. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial , 2007, Annals of the rheumatic diseases.
[213] M. Iwaki,et al. Absorption of indomethacin and its calcium salt through rat skin: effect of penetration enhancers and relationship between in vivo and in vitro penetration. , 1986, Journal of pharmacobio-dynamics.
[214] Bozena Michniak,et al. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[215] I. Takahashi,et al. Daily subcutaneous erythropoietin by jet injection in pediatric dialysis patients. , 1995, Nephron.
[216] K. Nakamura,et al. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. , 2001, International journal of pharmaceutics.
[217] M. Rashidi,et al. The effect of terpene concentrations on the skin penetration of diclofenac sodium. , 2007, International journal of pharmaceutics.
[218] G. H. Clowes,et al. ON DICHLOROETHYLSULFIDE (MUSTARD GAS) IV. THE MECHANISM OF ABSORPTION BY THE SKIN , 1919 .
[219] Y. Kalia,et al. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[220] A. Urtti,et al. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[221] Chong-Kook Kim,et al. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. , 2005, Biomaterials.
[222] R. Guy,et al. Reverse Iontophoresis as a Noninvasive Tool for Lithium Monitoring and Pharmacokinetic Profiling , 2004, Pharmaceutical Research.
[223] B. Finnin,et al. The transdermal revolution. , 2004, Drug discovery today.
[224] H. Benson,et al. Transdermal drug delivery: penetration enhancement techniques. , 2005, Current drug delivery.
[225] B. Bellhouse,et al. Transdermal and transmucosal powdered drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.
[226] S. Tenjarla,et al. Synthesis and evaluation of N-acetylprolinate esters - novel skin penetration enhancers. , 1999, International journal of pharmaceutics.
[227] B. W. Barry,et al. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. , 1988, The Journal of investigative dermatology.
[228] Y. Kalia,et al. Ultrasound-enhanced transdermal transport. , 2003, Journal of pharmaceutical sciences.
[229] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[230] Adrian C. Williams,et al. Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.
[231] B. W. Barry,et al. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin , 1987, The Journal of pharmacy and pharmacology.
[232] Sanyog Jain,et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. , 2005, International journal of pharmaceutics.
[233] Q. Ping,et al. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. , 2000, Drug delivery.
[234] Y. Gross,et al. A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules , 1997 .
[235] K. Takayama,et al. Transdermal delivery of indomethacin by iontophoresis. , 2002, Biological & pharmaceutical bulletin.
[236] Y. Kawano,et al. Evaluation of the interaction of surfactants with stratum corneum model membrane from Bothrops jararaca by DSC. , 2006, International journal of pharmaceutics.
[237] Susan F. Paparella. Transdermal patches: an unseen risk for harm. , 2005, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.
[238] Shao Jun Jiang,et al. Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. , 2003, Biological & pharmaceutical bulletin.
[239] N. Weiner,et al. Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. , 1990, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[240] Dorian Liepmann,et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[241] Ju-Hyun Kim,et al. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. , 2002, International journal of pharmaceutics.
[242] R. Stout,et al. Studies on the use of needle-free injection device on proteins. , 2005, Journal of chromatography. A.
[243] Samir Mitragotri,et al. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. , 2003, Biophysical journal.
[244] S. B. Tiwari,et al. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. , 2003, International journal of pharmaceutics.
[245] Véronique Préat,et al. Topical Gene Transfer into Rat Skin Using Electroporation , 2004, Pharmaceutical Research.
[246] I. Power,et al. Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain. , 2007, British journal of anaesthesia.
[247] Murthy Sn,et al. Magnetophoresis: an approach to enhance transdermal drug diffusion. , 1999 .
[248] Y-P Fang,et al. Enhancement of topical 5‐aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation , 2004, The British journal of dermatology.
[249] O. Pillai,et al. Transdermal Iontophoresis of Insulin , 2004, Skin Pharmacology and Physiology.
[250] D. Rabussay,et al. Topical Delivery of Lidocaine in Healthy Volunteers by Electroporation, Electroincorporation, or Iontophoresis: An Evaluation of Skin Anesthesia , 2000, Regional Anesthesia & Pain Medicine.
[251] B. Godin,et al. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[252] M. Schäfer-Korting,et al. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[253] Bai Xu,et al. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. , 2005, Nanomedicine : nanotechnology, biology, and medicine.
[254] C. Rhodes,et al. Preparation and characterization of liposomes as therapeutic delivery systems: a review. , 1995, Pharmaceutica acta Helvetiae.
[255] P. Wertz,et al. Essential fatty acids and epidermal integrity. , 1987, Archives of dermatology.
[256] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[257] Jagdish Singh,et al. Effect of Chemical Penetration Enhancer and Iontophoresis on the In Vitro Percutaneous Absorption Enhancement of Insulin Through Porcine Epidermis , 2005, Pharmaceutical development and technology.
[258] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[259] P. Reddy,et al. Recent Advances in Novel Drug Delivery Systems , 2003 .
[260] K. Bain. A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications. , 2006, Journal of opioid management.
[261] B. W. Barry,et al. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[262] P. Minghetti,et al. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[263] Chong-K. Kim,et al. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. , 2004, Biomaterials.
[264] Göran Stemme,et al. Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.
[265] M. Mezei,et al. Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.
[266] J. Hadgraft,et al. Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid. , 2003, International journal of pharmaceutics.
[267] Sanyog Jain,et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.
[268] R. Scheuplein,et al. Permeability of the skin. , 1971, Physiological reviews.
[269] A. Güleç,et al. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study , 2005, International journal of dermatology.
[270] J. Hadgraft,et al. Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues , 1996 .
[271] S. Lundin,et al. Administration of antidiuretic peptide (DDAVP) by way of suction de-epithelialised skin , 1991, The Lancet.
[272] G. Cevc,et al. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. , 2003, Biochimica et biophysica acta.
[273] S. González,et al. Transdermal microconduits by microscission for drug delivery and sample acquisition , 2004, BMC medicine.
[274] J Hadgraft,et al. Crystallization of hydrocortisone acetate: influence of polymers. , 2001, International journal of pharmaceutics.
[275] J Hadgraft,et al. Membrane penetration enhancement of ibuprofen using supersaturation. , 2000, International journal of pharmaceutics.
[276] N. Yata,et al. Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. , 1999, Journal of drug targeting.
[277] A. Doukas,et al. Photomechanical transdermal delivery of insulin in vivo , 2001, Lasers in surgery and medicine.
[278] B. Michniak,et al. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin , 2003, AAPS PharmSci.
[279] Samir Mitragotri,et al. Current status and future prospects of needle-free liquid jet injectors , 2006, Nature Reviews Drug Discovery.
[280] P. Elsner,et al. Skin roughness is negatively correlated to irritation with DMSO, but not with NaOH and SLS , 1997, Experimental dermatology.
[281] A. Banga,et al. Electrically Modulated Transdermal Delivery of Fentanyl , 2002, Pharmaceutical Research.
[282] Dae-Duk Kim,et al. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery. , 2003, Journal of pharmaceutical sciences.
[283] S. Scheindlin. Transdermal drug delivery: PAST, PRESENT, FUTURE. , 2004, Molecular interventions.
[284] Yannic B Schuetz,et al. Emerging strategies for the transdermal delivery of peptide and protein drugs , 2005, Expert opinion on drug delivery.
[285] J. Bouwstra,et al. Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies , 1996 .
[286] Samir Mitragotri,et al. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.
[287] M. Fujii,et al. Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. , 1994, Chemical & pharmaceutical bulletin.
[288] R. Birnbacher,et al. Painfulness of needle and jet injection in children with diabetes mellitus , 1994, European Journal of Pediatrics.
[289] O. Katare,et al. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. , 2001, International journal of pharmaceutics.
[290] S. Lundin,et al. Absorption of an Oxytocin Antagonist (Antocin) and a Vasopressin Analogue (dDAVP) Through a Standardized Skin Erosion in Volunteers , 1995, Pharmaceutical Research.
[291] M. Rother,et al. randomised controlled trial placebo in osteoarthritis of the knee: multicentre and Transfersome®(IDEA-033) versus oral celecoxib Efficacy and safety of epicutaneous ketoprofen in , 2007 .
[292] A. Sintov,et al. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[293] S. Shen,et al. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[294] E. Peira,et al. Influence of ion pairing on topical delivery of retinoic acid from microemulsions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[295] J. Pandit,et al. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. , 2005, International journal of pharmaceutics.
[296] Y. Kalia,et al. Electrorepulsion Versus Electroosmosis: Effect of pH on the lontophoretic Flux of 5-Fluorouracil , 1999, Pharmaceutical Research.